Skip to main content

Table 2 MNAT1 expressions in CRC samples at various clinical stages

From: RETRACTED ARTICLE: MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance

Characteristic

Cases

MNAT1 expression

p

Low(%)

High(%)

All patients

 Gender

  Male

57

35(61.4)

22(38.6)

0.817

  Female

43

29(67.4)

14(32.6)

 

 Age (yrs)

   < 50

34

16(47.1)

18(52.9)

0.770

   ≥ 50

66

35(53.0)

31(47.0)

 

 T stage

  T1-T2

37

19(51.3)

18(48.7)

0.882

  T3-T4

63

34(53.9)

29(46.1)

 

 N stage

  N0

39

17(43.6)

22(56.4)

0.891

  N1-N3

61

29(47.5)

32(52.5)

 

 M stage

  M0

34

18(52.9)

16(47.1)

0.897

  M1

66

35(53.0)

31(47.0)

Â